Further study on the microbial transformation of curcumol (1) by Cunninghamella blakesleana (AS3.970) led to the isolation of four novel metabolites. Their structures were elucidated as 3b b-hydroxy curcumol (2), 12-hydroxy curcumol (3), 1a a-hydroxy-10b b,14-epoxy curcumol (4) 
essential oil was currently embodied in the Pharmacopoeia of the P. R. China (2005) , as an anti-cancer and anti-virus remedy.
2) It showed that the Ezhu intravenous injection made from C. wenyujin has high anti virus activity in treating respiratory syncytial virus (RSV) in infant therapy. 3, 4) Curcumol, one of the major components of the essential oil with the structure of sesquiterpene hemiacetal, was found to have obvious anti-tumor activity.
5) The structure of curcumol was identified on the basis of chemical and spectral data in 1965, 6) and its stereostructure was determined by X-ray analysis in 1984. 7) As an anti-tumor and anti-virus agent, curcumol has the disadvantages of poor solubility in water and rather strong toxicity (ID 50 of rats is 250 mg/kg). Thus, further structural modifications of curcumol to generate new analogs with increased water solubility, improved bioactivity and less toxic, may provide high utility in cancer and other diseases treatment.
Up to now, structural modifications of curcumol by biological methods have not been performed. The species of Cunninghamella have been reported to be able to catalyze specific hydroxylation of substrates. 8, 9) In our previous study, we used Cunninghamella blakesleana (AS 3.970) to transform curcumol, and yielded six metabolites. 10) Further study led to the isolation of other four novel metabolites. In this paper, we'll describe the isolation and determination of the four novel metabolites.
Results and Discussion
Curcumol (1) was administered to the 2-d-old microorganism cultures, and four more polar metabolites were obtained after additional 5 d of incubation. On the basis of physicochemical evidences and the spectroscopic analysis, their structures were identified as: 3b-hydroxy curcumol (2), 12-hydroxy curcumol (3), 1a-hydroxy-10b,14-epoxy curcumol (4) and (2S,4S,5S,7S)-10-hydroxymethyl-7-isopropyl-2-methoxy-4-methyl-1-oxaspiro [4, 6] undec-10-en-8-one (5) (see Fig. 1 ). The 13 C-and 1 H-NMR spectral data were assigned using 2D-NMR techniques in Tables 1 and 2 .
The HR-ESI-MS analysis of compound 2 (m/z 253.1796
[MϩH] ϩ ) indicated the molecular formula C 15 H 24 O 3 in combination with the 1 H-and 13 C-NMR spectral data, which had one more oxygen than that of the substrate molecule, revealing that 2 might be a hydroxylated product of curcumol. In the 1 H-NMR spectrum, an additional signal assigned to H-3 was observed at d 4.09 (1H, br s) in contrast with that of 1. The 13 C-NMR spectrum of 2 exhibited an additional oxygenbearing methine signal at d 74.9, suggesting the introduction of a hydroxyl group in the molecule. Its location was deduced to be at C-3 by the long-range coupling from 15-methyl protons (d 1. The configuration of C-11 was established to be R based on the NOESY spectrum, in which H-12 correalted with H-6, H-11 correlated with H-9, and H-13 correlated with H-9. Therefore, the structure of 3 was identified as 12-hydroxy-(11R)-curcumol.
The suggested the a-configuration of C-14. Thus, the structure of metabolite 4 was identified as 1a-hydroxy-10b,14-epoxy curcumol. The proton and carbon NMR spectra data were assigned in Tables 1 and 2 , and from H-6 to C-5 in the HMBC spectrum revealed the structure of ring B as 10-hydroxymethyl-7-isopropyl-10-en-8-one, which was attached to ring A at C-5 to form a spiro-ring. This conclusion was further supported by the HMBC correlations from H-6 to C-4 and C-11, from H-11 to C-6 and C-4, and from H-4 to C-6 and C-11. All the 1 H-and 13 C-NMR data were assigned according to extensive NMR techniques (DEPT, 1 H-1 H COSY, HSQC and HMBC) (see Tables 1 and 2 ) and the configuration of 5 was established by the NOESY spectrum (see Fig. 2 ). In conclusion, the structure of metabolite 5 was elucidated as (2S,4S,5S,7S)-10-hydroxymethyl-7-isopropyl-2-methoxy-4-methyl-1-oxaspiro [4, 6] undec-10-en-8-one.
Experimental
IR spectra were conducted on a Bruker IFS 55 spectrophotometer (KBr). Optical rotation values were measured by using a Perkin-Elmer 243B polarimeter. NMR spectra ( 1 H-, C-NMR, 100 MHz) and chemical shifts were recorded in ppm using TMS as internal standard. ESI-MS spectra were measured on a Bruker esquire 2000 in the positive mode. HPLC was carried out on Waters 600 (Waters, U.S.A.) with PDA996 (Waters, U.S.A.) as the detector, using the reversed phase column (Techsphere C 18 , 5 mm, 4.6ϫ250 mm, for analysis and Inertsil C 18 Prepare column 20.0ϫ250 mm, for preparation). Silica gel for column chromatography and TLC were obtained from Qingdao Oceanic Chemical Factory. All chemicals were obtained from Shenyang Chemical Factory.
Microorganisms Cunninghamella blakesleana (AS3.970) which were purchased from China General Microbiological Culture Collection Center, was gifted from Dr. Dean Guo.
Substrate Material Curcumol 1 (99% as the pureness, detected with HPLC) was isolated from the essential oil of Curcuma wenyujin, and characterized by chemical and spectral methods as described in the literature.
11)
The substrate was dissolved in acetone and diluted to 4.0 mg/ml before use.
Medium All culture and biotransformation experiments were performed in potato medium, which was produced by the following procedure: 200 g of minced husked potato were boiled in water for an hour, then the extract was filtered and the filtrate were added with water to 1 l after addition of 20 g of glucose.
Biotransformation The screen-scale biotransformation was performed in 250 ml Erlenmeyer flasks containing 60 ml potato media. Twenty-nine kinds of microorganisms were transferred into the flasks from the slants respectively. The cultures were cultivated on rotary shakers at 180 rpm, 25°C. One milliliter of the substrate solution was added into each flask with 2-dold microorganism cultures, and 1 ml of acetone alone instead of substrate solution into each parallel flask as the culture control. Substrate controls consisted of sterile media containing the same amount of substrate and incubated under the same conditions. After further 5 d of incubation, the broth was filtered under vacuum and the filtrate was extracted with the equivalent volume of ethyl acetate for three times. The dried mycelium were extracted with acetone (3ϫ50 ml) at room temperature and filtered under vacuum. All the extract were pooled respectively and evaporated under reduced pressure at 45°C to give residue. Then the residue was dissolved in methanol and spotted on silica gel plates which were developed by cyclohexane-acetone (2 : 1), and visualized by spraying with 10% H 2 SO 4 (in EtOH), followed by heating at about 100°C. For preparative biotransformation, 2 g of substrate were distributed into shake flasks with 2-d-old microorganism cultures, and after another 5 d of incubation, the culture media were collected, extracted and concentrated as described above.
Isolation and Purification of the Metabolites The obtained residue (5.6 g) was separated on a silica gel (200-300 mesh) column (f35ϫ420 mm), eluted with cyclohexane-acetone (100, 100 : 1, 100 : 3, 100 : 5, 10 : 1, 5 : 1, 2 : 1, 1 : 1, 1500 ml for each gradient eluent) to give fractions I-XII. Fraction IX (1.5 g) was subjected to silica gel column (f30ϫ450 mm) chromatography, eluted with a mixture of cyclohexane-acetone (20 : 1, 10 : 1, 5 : 1, 2 : 1, 1000 ml for each gradient eluent) to give fraction A-J, among which fraction G and H were further separated by preparative HPLC (Inertsil C 18 Prepare column f20ϫ250 mm, 55% MeOH/H 2 O as mobile phase, flow rate: 8 ml/min) to yield 2 (26.3 mg) and 3 (18.5 mg). Fraction VIII (1.0 g) was subjected to silica gel column (f35ϫ280 mm) chromatography, eluted with cyclohexane-acetone (50 : 1, 20 : 1, 10 : 1, 5 : 1, 500 ml for each gradient eluent) to yield 4 (3.5 mg) as crystals (between Fig. 2 . The NOESY Correlations of Metabolite 5 1000 ml and 1500 ml). Fraction X was subjected to silica gel column (f30ϫ450 mm) chromatography, eluted with a mixture of cyclohexane-acetone (20 : 1, 10 : 1, 5 : 1, 2 : 1, 1 : 1, 1000 ml for each gradient eluent) to give fraction A-L, among which fraction D was further separated by preparative HPLC (Inertsil C 18 Prepare column f20ϫ250 mm, 50% MeOH/H 2 O as mobile phase, flow rate: 8 ml/min) to yield 5 (2.2 mg). Tables 1 and 2. 1a-Hydroxy-10b,14-epoxy Curcumol (4) Tables 1 and 2. (2S,4S,5S,7S)-10-Hydroxymethyl-7-isopropyl-2-methoxy-4-methyl-1-oxaspiro [4, 6] Tables  1 and 2. 
